Aquaporins as targets for drug discovery

Current Pharmaceutical Design

Volumn 13, Issue 23, 2007, Pages 2421-2427

  Frigeri, Antonio ^a   Nicchia, Grazia Paola ^a   Svelto, Maria ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

AQPs; Aquaporins; Brain edema; Drug discovery; Inhibitors; Tumous; Water channels

Indexed keywords

AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT; AQUAPORIN; AQUAPORIN 1; AQUAPORIN 3; AQUAPORIN 4 INHIBITOR; AQUAPORIN 4 MODULATOR; AQUAPORIN 5; AQUAPORIN 7; AQUAPORIN 9; AQUAPORIN INHIBITOR; MANNITOL; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VASOPRESSIN;

ATOPIC DERMATITIS; BRAIN DECOMPRESSION; BRAIN EDEMA; CELL MEMBRANE PERMEABILITY; CONGENITAL CATARACT; DRUG DETERMINATION; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; ELECTROLYTE TRANSPORT; EPILEPSY; GLAUCOMA; HORMONAL REGULATION; HUMAN; HYDROSTATIC PRESSURE; HYPONATREMIA; KIDNEY TUBULE ABSORPTION; MULTIPLE MYELOMA; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; OBESITY; OSMOTIC PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA INTERFERENCE; SJOEGREN SYNDROME; WATER ABSORPTION; WATER TRANSPORT;

ANIMALS; AQUAPORINS; BRAIN; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; EYE; HUMANS; KIDNEY; MEMBRANE TRANSPORT MODULATORS; NEOPLASMS; OBESITY; SALIVARY GLANDS; SKIN; WATER; WATER-ELECTROLYTE BALANCE;

EID: 34548252981     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207781368738     Document Type: Review

References (103)

1. Agre P, Kozono D. Aquaporin water channels: Molecular mechanisms for human diseases. FEBS Lett 2003; 555: 72-8.
2. Verkman AS, Mitra AK. Structure and function of aquaporin water channels. Am J Physiol Renal Physiol 2000; 278: F13-28.
3. Hara-Chikuma M, Verkman AS. Physiological roles of glycerol-transporting aquaporins: The aquaglycemporins. Cell Mol Life Sci 2006; 63: 1386-92
4. Agre P, King LS, Yasui M, Guggino WB, Ottersen OP, Fujiyoshi Y, et al. Aquaporin water channels-from atomic structure to clinical medicine. J Physiol 2002; 542: 3-16. Review.
5. Fujiyoshi Y, Mitsuoka K, de Groot BL, Philippsen A, Grubmuller H, Agire P, et al. Structure and function of water channels. Curr Opin Struct Biol 2002; 4: 509-15. Review.
6. de Mattia, F, Savelkoul PJ, Kamsteeg EJ, Konings IB, van der Sluijs P, Mallmann R, et al. Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus. J Am Soc Nephrol 2005; 16: 2872-80.
7. Varadaraj K, Kumari S, Shiels A, Mathias RT. Regulation of aquaporin water permeability in the lens. Invest Ophthalmol Vis Sci 2005; 46: 1393-402.
8. Arima H, Yamamoto N, Sobue K, Umenishi F, Tada T, Katsuya H, et al. Hyperosmolar mannitol simulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase-dependent pathway in rat astrocytes. J Biol Chem 2003; 278: 44525-34.
9. Knepper MA. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol 1997; 272: F3-12.
10. Yasui M, Hazama A, Kwon TH, Nielsen S, Guggino WB, Agre P. Rapid gating and anion permeability of an intracellular aquaporin. Nature 1999; 402: 184-7.
11. Preston GM, Carroll TP, Guggino WB, Agre P. Appearance of water channels in Xenopus oocytes expressing red Cell CHIP28 protein. Science 1992; 256: 385-7.
12. Nielsen S, Smith BL, Christensen EI, Agre P. Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia. Proc Natl Acad Sci USA 1993; 90: 7275-9
13. Verkman AS. Renal concentrating and diluting function in deficiency of specific aquaporin genes. Exp Nephrol 2002; 10: 235-40.
14. King LS, Choi M, Fernandez PC, Cartron JP, Agre P. Defective urinary-concentrating ability due to a complete deficiency of aquaporin-1. N Engl J Med 2001; 345: 175-9.
15. Frigeri A, Gropper MA, Turck CW, Verkman AS. Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci USA 1995b; 92: 4328-31.
16. Terris J, Ecelbarger CA, Marples D, Knepper MA, Nielsen S. Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol 1995; 269: F775-85.
17. Ecelbarger CA, Terris J, Frindt G, Echevarria M, Marples D, Nielsen S, et al. Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol 1995; 269: F663-72
18. Verkman AS. Novel roles of aquaporins revealed by phenotype analysis of knockout mice. Rev Physiol Biochem Pharmacol 2005; 155: 31-55.
19. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 1993; 361: 549-52.
20. Bichet Dd. Nephrogenic diabetes insipidus. Am J Med 1998; 105: 431-42
21. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994; 264: 92-5.
22. Kamsteeg EJ, Bichet DG, Konings IB, Nivet H, Lonergan M, Arthus MF, et al. Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus. J Cell Biol 2003; 163: 1099-109.
23. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: From molecules to medicine. Physiol Rev 2002; 82: 205-44.
24. Schrier RW, Cadnapaphornchai MA, Ohara M. Water retention and aquaporins in heart failure, liver disease and pregnancy. J R Soc Med 2001; 94: 265-9. Review.
25. Kim SW, Wang W, Kwon TH, Knepper MA, Frokiaer J, Nielsen S. Increased expression of ENaC subunits and increased apical targeting of AQP2 in the kidneys of spontaneously hypertensive rats. Am J Physiol Renal Physiol 2005; 289: F957-68.
26. Lee J, Kim S, Kim J, Jeong MH, Oh Y, Choi KC. Increased expression of renal aquaporin water channels in spontaneously hypertensive rats. Kidney Blood Press Res 2006; 29: 18-23.
27. Itoh T, Rai T, Kuwahara M, Ko SB, Uchida S, Sasaki S, et al. Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. Biochem Biophys Res Commun 2005; 330: 832-8.
28. Yakata K, Hiroaki Y, Ishibashi K, Sohara. E, Sasaki S, Mitsuoka, K, et al. Aquaporin-11 containing a divergent NPA motif has normal water channel activity. Biochim Biophys Acta 2007; 1768(3): 688-93.
29. Berry V, Francis P, Kaushal S, Moore A, Bhattacharya S Missense mutations in MIP underlie autosomal dominant 'polymorphic' and lamellar cataracts linked to l2q. Nat Genet 2000; 25: 15-7.
30. Geyer DD, Spence MA, Johannes M, Flodman P, Clancy KP, Berry R, et al. Novel single-base deletional mutation in major intrinsic protein (MIP) in autosomal dominant cataract. Am J Ophthalmol 2006; 141: 761-3.
31. Buzhynskyy N, Hite RK, Walz T, Scheuring S. The supramolecular architecture of junctional microdomains in native lens membranes. EMBO Rep 2007; 8(1): 51-5.
32. Frigeri A, Gropper MA, Turck CW, Verkman AS. Immunolocalization of the mercurial-insensitive water channel and glycerol intringic protein in epithelial cell plasma membranes. Proc Natl Acad Sci USA 1995; 92: 4328-31.
33. Zhang D, Vetrivel L, Verkman AS. Aquaporin deletion in mice reduces intraocular pressure and aqueous fluid production. J Gen Physiol 2002; 119: 561-9.
34. Kimelberg HK, Ransom BR. Physiological and pathological aspects of astrocytic swelling. In: Federoff S, Vernadakis A Eds. Astrocytes. Cell biology and pathology of astrocytes. San Diego, CA, Academic Press. 1986; 77-127.
35. Montgomery DL. Astrocytes: Form, functions, and roles in desease. Vet Pathol 1994; 31: 145-67.
36. Oshio K, Watanabe H, Song Y, Verkman AS, Manley GT. Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1. FASEB J 2005; 19: 76-8.
37. Nicchia GP, Frigeri A, Nico B, Ribatti D, Svelto M. Tissue distribution and membrane localization of aquaporin-9 water channel: Evidence for sex-linked differences in liver. J Histochem Cytochem 2001; 49; 1547-56.
38. Elkjaer M, Vajda Z, Nejsum LN, Kwon T, Jensen UB, Amiry-Moghaddam M, et al. Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. Biochem Biophys Res Commun 2000; 276: 1118-28.
39. Badaut J, Petit JM, Brunet JF, Magistretti PJ, Charriaut-Marlangue C, Regli L. Distribution of Aquaporin 9 in the adult rat brain: preferential expression in catecholaminergic neurons and in glial cells. Neuroscience 2004; 128: 27-38.
40. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997; 17: 171-80.
41. Saadoun S, Papadopoulos MC, Davies DC, Bell BA, Krishna S. Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancer 2002; 87: 621-3.
42. Badaut J, Brunet JF, Grollimund L, Hamou MF, Magistretti PJ, Villemure JG, et al. Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue Acta Neurochir Suppl 2003; 86: 495-8.
43. Papadopoulos MC, Saadoun S, Binder DK, Manley GT, Krishna S, Verkman AS. Molecular mechanisms of brain tumor edema. Neuroscience 2004; 129: 1011-20. Review.
44. Suzuki R, Okuda M, Asai J, Nagashima G, Itokawa H, Matsunaga A, et al. Astrocytes co-express aquaporin-1, -4, and vascular endothelial growth factor in brain edema tissue associated with brain contusion. Acta Neurochir Suppl 2006; 96: 398401.
45. Rodriguez A, Perez-Gracia E, Espinosa JC, Pumarola M, Torres JM, Ferrer I. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice. Acta Neuropathol (Bert) 2006; 112(5): 573-85.
46. Frigeri A, Nicchia GP, Nico B, Quondamatteo F, Herken R, Roncali L, et al. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx-mice. FASEB J 2001a; 1: 90-7.
47. Vajda Z, Pedersen M, Fuchtbauer EM, Wertz K, Stodkilde-Jorgensen H, Sulyok E, et al. Delayed onset of brain edema and mislocalization of aquaporin-4 in dystrophin-mill transgenic mice. Proc Natl Acad Sci USA 2002; 99: 13131-6.
48. Amiry-Moghaddam M, Otsuka T, Hum PD, Traystman RJ, Haug FM, Froehner SC, et al. An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain. Proc Natl Acad Sci USA 2003; 100: 2106-11.
49. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6: 159-63.
50. Papadopoulos MC, Verkman AS. Aquaporin-4 gene disruption in mice reduces brain swelling and mortality in pneumococcal meningitis. J Biol Chem 2005; 280: 13906-12.
51. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004; 18: 1291-3.
52. Frydenlund DS, Bhardwaj A, Otsuka T, Mylonakou MN, Yasumura T, Davidson KG, et al. Temporary loss of perivascular aquaporin-4 in neocortex after transient middle cerebral artery occlusion in mice. Proc Natl Acad Sci USA 2006; 103: 13532-6.
53. Ribeiro Mde C, Hirt L, Bogousslavsky J, Regli L, Badaut J. Time course of aquaporin expression after transient focal cerebral ischemia in mice. J Neurosci Res 2006; 83: 1231-40.
54. Li J, Verkman AS. Impaired hearing in mice lacking aquaporin-4 water channels. J Biol Chem 2001; 276: 31233-7.
55. Amiry-Moghaddam M, Williamson A, Palomba M, Eid T, de Lancerolle NC, Nagelhus EA, et al. Delayed K+ clearance associated with aquaporin-4 mislocalization: Phenotypic defects in brains of alpha-syntrophin-null mice. Proc Natl Acad Sci USA 2003; 100: 13615-20.
56. Binder DK, Oshio K, Ma T, Verkman AS, Manley GT. Increased seizure threshold in mice lacking aquaporin-4 water channels. NeuroReport 2004; 15: 259-62.
57. Ma T, Song Y, Gillespie A, Carlson EJ, Epstein CJ, Verkman AS. Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels. J Biol Chem 1999; 274: 20071-4
58. Krane CM, Melvin JE, Nguyen HV, Richardson L, Towne JE, Doetschman T, et al. Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation. J Biol Chem 2001; 276: 23413-20.
59. Tsubota K, Hirai S, King LS, Agre P, Ishida N. Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjogren's syndrome. Lancet 2001; 357: 688-9.
60. Steinfeld S, Cogan E, King LS, Agre P, Kiss R, Delporte C. Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjogren's syndrome patients. Lab Invest 2001; 81: 143-8.
61. Mandic R, Teymoortash A, Kann PH, Werner JA. Sialadenosis of the major salivary glands in a patient with central diabetes insipidus-implications of aquaporin water channels in the pathomechanism of sialadenosis. Exp Clin Endocrinol Diabetes 2005; 113: 205-7.
62. Devorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999; 237: 97-132. Review.
63. Vacca A, Ribatti D, Roccaro AM, Frigeri A, Dammacco F. Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol 2001; 28: 543-50. Review.
64. Vacca A, Frigeri A, Ribatti D, Nicchia GP, Nico B, Ria R, et al. Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma. Br J Haematol 2001; 113: 415-21.
65. Endo M, Jain RK, Witwer B, Brown D. Water channel (aquaporin 1) expression and distribution in mammary carcinomas and glioblastomas. Microvasc Res 1999; 58: 89-98.
66. Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 2005; 434: 786-92.
67. Hibuse T, Maeda N, Funahashi T, Yamamoto K, Nagasawa A, Mizunoya W, et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci USA 2005; 102: 10993-8.
68. Maeda N, Funahashi T, Hibuse T, Nagasawa A, Kishida K, Kuriyama H, et al. Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proc Natl Acad Sci USA 2004; 101: 17801-6.
69. Hara-Chikuma M, Sohara E, Rai T, Ikawa M, Okabe M, Sasaki. S, et al. Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J Biol Chem 2005; 280: 15493-6.
70. Kondo H, Shimomura I, Kishida K, Kuriyama H, Makino Y, Nishizawa H, et al. Human aquaporin adipose (AQPap) gene. Genomic structure, promoter analysis and functional mutation. Eur J Biochem 2002; 269: 1814-26.
71. Brown D, Grosso A, de Sousa RC. Isoproterenol-induced intramembrane particle aggregation and water flux in toad epidermis. Biochim Biophys Acta 1980; 596: 158-164.
72. Hara M, Ma T, Verkman AS. Selectively reduced glycerol in skin of aquaporin-3-deficient mice may account for impaired skin hydration, elasticity, and barrier recovery. J Biol Chem 2002; 277: 46616-21.
73. Nara M, Verkman AS. Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-deficient mice. Proc Natl Acad Sci USA 2003; 100: 7360-5.
74. Boury-Jamot M, Sougrat R, Tailhardat M, Varlet BL, Boate F, Dumas M, et al. Expression and function of aquaporins in human skin: Is aquaporin-3 just a glycerol transporter? Biochim Biophys Acta 2006; 1758: 1034-42.
75. Olsson M, Broberg A, Jemas M, Carlsson L, Rudemo M, Suurkula M, et al. Increased expression of aquaporin 3 in atopic eczema. Allergy 2006; 61: 1132-7.
76. Zeidel ML, Nielsen S, Smith BL, Ambudkar, SV, Maunsbach AB, Agre P. Ultrastructure, pharmacologic inhibition, and transport selectivity of aquaporin channel-forming integral protein in proteoliposomes. Biochemistry (1994) 33: 1606-15.
77. Zhang R, van Hoek AN, Biwersi J, Verkman AS. A point mutation at cysteine 189 blocks the water permeability of rat kidney water channel CHIP28k. Biochemistry 1993; 32: 2938-41.
78. Niemietz CM, Tyerman SD. New patent inhibitors of aquaporins: Silver and gold compounds inhibit aquaporins of plant and human origin. FEBS Lett 2002; 531: 443-7.
79. Brooks HL, Regan JW, Yool AJ. Inhibition of aquaporin-1 water permeability by tetraethylammonium: Involvement of the loop E pore region. Mol Pharmacol 2000; 57: 1021-6.
80. Yool AJ, Brokl OH, Pannabecker TL, Dantzler WH, Stamer WD. Tetraethylammonium block of water flux in Aquaporin-1 channels expressed in kidney thin limbs of Henle's loop and a kidney-derived cell line. BMC Physiol 2002; 2: 4.
81. Armstrong CM. Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J Gen Physiol 1971; 58: 413-37.
82. + channel from transverse tubule membranes isolated from rabbit skeletal muscle. Proc Natl Acad Sci USA 1982; 79: 805-9.
83. + channels in a pituitary cell line. J Physiol 1990; 425: 117-32.
84. Bissada NK, Welch LT, Finkbeiner AE. Uropharmacology: VII. Ganglionic stimulating and blocking agents. Urology 1978; 11: 425-31.
85. Detmers FJ, de Groot BL, Muller EM, Hinton A, Konings IB, Sze M, et al. Quaternary ammonium compounds as water channel blockers. Specificity, potency, and site of action. J Biol Chem 2006; 281: 14207-14.
86. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-8.
87. Matzke MA, Matzke AJ, Pruss GJ, Vance VB. RNA-based silencing strategies in plants. Curr Opin Genet Dev 2001; 11: 221-7.
88. Cogoni C. Homology-dependent gene silencing mechanisms in fungi. Annu Rev Microbiol 2001. 55: 381-406.
89. Harborth J, Elbashir SM, Bechert K, Tuschl T, Weber K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 2110; 114: 4557-65.
90. Zimmermann TS, Lee, AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN, et al. RNAi-mediated gene silencing in non-human primates. Nature 2006; 441: 111-4.
91. Nicchia GP, Frigeri A, Liuzzi MG, Svelto M. Inhibition of aquaporth-4 expression in astrocytes by RNAi determines alterations in cell morphology, growth and water transport and induces changes in ischemia related genes. FASEB J 2003; 17: 1508-10.
92. Nicchia GP, Srinivas M, Li W, Brosnan CF, Frigeri A, Spray DC. New possible roles for aquaporin-4 in astrocytes: Cell cytoskeleton and functional relationship with connexin43. FASEB J 2005; 19: 1674-6.
93. Camerino GM, Nicchia GP, Dinardo MM, Ribatti D, Svelto M, Frigeri A. In vivo silencing of Aquaporin-1 by RNA interference inhibits angiogensis in the chick embryo chorioallantoic membrane assay. Cell Mol Biol 2006; 7: 51-6.
94. Siragy HM. Hyponatremia, fluid-electrolyte disorders, and the syndrome of inappropriate antidiuretic hormone secretion: Diagnosis and treatment options. Endocr Pract 2006; 12: 446-57.
95. Farinas J, Simanek V, Verkman AS. Cell volume measured by total internal reflection microfluorimetry: Application to water and solute transport in cells transfected with water channel homologs.Biophys J 1995; 68: 1613-20.
96. Farinas J, Kneen M, Moore M, Verkman AS. Plasma membrane water permeability of cultured cells and epithelia measured by light microscopy with spatial filtering. J Gen Physiol 1997; 110: 283-96.
97. Farinas J, Verkman AS. Cell volume and plasma membrane osmotic water permeability in epithelial cell layers measured by interferometry. Biophys J 1996; 71: 3511-22.
98. Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci USA 1993; 90:11663-7
99. Jain KK. The role of nanobiotechnology in drug discovery. Drug Discov Today 2005; 10: 1435-42.
100. Wang J. On-chip enzymatic assays. Electrophoresis 2002; 23: 713-8.
101. D'Andrea MR, Nagele RG. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr Pharm Des 2006; 12(6): 677-84.
102. Gotti C, Rigand L, Vailati S, Clementi F. Brain neuronal nicotinic receptors as new targets for drug discovery. Curr Pharm. Des 2006; 12(4): 407-28.
103. Kostenis E. G proteins in drug screening: From analysis of receptor-G protein specificity to manipulation of OPCR-mediated signalling pathways. Curr Pharm Des 2006; 12(14): 1703-15.